Leo Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 11-01-2025
- Paid Up Capital ₹ 1.50 M
as on 11-01-2025
- Company Age 21 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 11-01-2025
- Satisfied Charges ₹ 2.70 Cr
as on 11-01-2025
- Revenue 60.62%
(FY 2022)
- Profit 46.64%
(FY 2022)
- Ebitda 29.12%
(FY 2022)
- Net Worth 61.85%
(FY 2022)
- Total Assets 75.14%
(FY 2022)
About Leo Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹2.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Devam Mody, Arvind Mody, and Anita Mody serve as directors at the Company.
- CIN/LLPIN
U24231GJ2003PTC042590
- Company No.
042590
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Leo Formulations Private Limited offer?
Leo Formulations Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Anti Infective Drugs & Medicines, Anti Allergic Drug, Nutraceuticals & Dietary Supplements, Dietary Supplements, Ayurvedic, Herbal Oils and Cosmetics, Herbal Body Lotion, Antihistamines, Injectable Products.
Who are the key members and board of directors at Leo Formulations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devam Mody  | Director | 09-Jul-2003 | Current |
| Arvind Mody | Director | 09-Jul-2003 | Current |
| Anita Mody | Director | 01-Dec-2004 | Current |
Financial Performance of Leo Formulations.
Leo Formulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 60.62% increase. The company also saw a substantial improvement in profitability, with a 46.64% increase in profit. The company's net worth Soared by an impressive increase of 61.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Leo Formulations?
In 2022, Leo Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Jun 2020 | ₹2.00 Cr | Open |
Others Creation Date: 27 Jun 2018 | ₹1.50 Cr | Satisfied |
Siddhi Co. Op. Bank Ltd Creation Date: 11 Oct 2012 | ₹2.10 M | Satisfied |
How Many Employees Work at Leo Formulations?
Leo Formulations has a workforce of 6 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leo Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leo Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
